13,525 analytical development jobs at 5,742 companies in United States
2w
Save
Mark Applied
Hide
2w
Director, Analytical Development
Aliso Viejo, California, United States
$225k-$250k/yrOnsiteFull Time
SpyGlass PharmaNASDAQ: SGP: Developing sustained drug delivery systems for chronic eye diseases.
10+ YOEPhD (or equivalent) and ≥10 years small‑molecule analytical development experience, expertise in chromatography/spectroscopy/mass spectrometry, cGMP knowledge, regulatory submission experience, and team leadership.
chromatography, spectroscopy, mass spectrometry, cGMP, ICH, USP, EP
MerckXETRA: MRK: A science and technology providing healthcare, life science, and electronics solutions.
4+ YOEExperience in analytical laboratory under GLP/cGMP with method development and use/troubleshooting of HPLC, GC, LCMS, ICPMS, DSC, TGA, KF, FTIR, NMR, and XRPD; ability to lead projects and document work.
Neion Bio: Develops an egg-based platform for scalable biomanufacturing of biologics.
5+ YOE5+ years industry experience in analytical development/characterization of mAbs or related biologics; Ph.D. or equivalent industry experience; hands-on experience with SEC-HPLC/UPLC, LC-MS, CE-SDS, ELISA, SPR/BLI; experience managing CROs and CMC/QA familiarity.
SEC-HPLC, UPLC, Ion-exchange, CE-SDS, capillary electrophoresis, LC-MS, ELISA, SPR, BLI
VaxcyteNASDAQ: PCVX: Developing vaccines to prevent and treat bacterial diseases.
Hands-on analytical development experience with HPLC/UPLC, CE, ELISA and related techniques; degree in chemistry/biochemistry/biology or related field; method development, troubleshooting, and documentation skills.
Stylus Medicine: Develops in vivo genetic medicines with recombinases and nanoparticles.
10+ YOEPhD in Biochemistry, Molecular Biology, or Chemical/Biological Engineering with 10+ years in analytical method development, validation, and regulatory submissions.
NGS, RNA-seq, ddPCR, RT-PCR, ELISA, DLS, LC, UV, MS
Tarsus PharmaceuticalsNASDAQ: TARS: Developing therapeutics for eye care and infectious disease prevention.
4+ YOEPhD (4+ yrs) or MS (8–12 yrs) in a relevant scientific discipline; experience with analytical method development/validation, CMC/regulatory support, leadership of external labs, and advanced analytical techniques.
Catalent: Global provider of drug development and manufacturing solutions.
4+ YOEDegree in physical/chemical/biological/pharmaceutical science and 1–4+ years analytical development experience; hands-on HPLC/UPLC method development, stability testing, GMP compliance, data interpretation, and client communication.
Keros TherapeuticsNASDAQ: KROS: Develops protein therapeutics for hematological and musculoskeletal disorders.
7+ YOELead analytical strategy and protein characterization for biologics; MS+10yrs or PhD+7yrs; expertise in protein characterization, method development, and regulatory CMC support.
Neurocrine BiosciencesNASDAQ: NBIX: Develops pharmaceuticals for neurological, endocrine, and psychiatric disorders.
3+ YOEAdvanced degree in chemistry or related field with 3+–5+ years analytical/pharmaceutical development experience; hands-on method development, validation, transfer, cGMP knowledge, and proficiency with HPLC, GC, MS, IC, NMR, KF, and related techniques.
Tarsus PharmaceuticalsNASDAQ: TARS: Develops and commercializes therapeutic treatments for prevalent ophthalmic diseases.
4+ YOEPhD with 4+ years or MS with 8–12 years pharmaceutical/biotech experience supporting analytical development; experience with HPLC/UPLC, GC, MS/LC-MS, stability, method development/validation, regulatory CMC documentation, and CRO/CDMO oversight.
ArdelyxNASDAQ: ARDX: Discovers and develops medicines for unmet medical needs.
10+ YOEBachelor's in chemistry or related field, 10+ years industry experience, strong analytical chemistry and cGMP experience, regulatory document preparation, outsourced partner management, budget and cross-functional collaboration skills.
Thermo Fisher ScientificNYSE: TMO: Sells equipment and chemicals for scientific research and healthcare.
3+ YOEExperience developing and applying HPLC/UHPLC analytical methods; ability to design experiments, analyze complex datasets, author technical documentation, and work in cross‑functional R&D teams. PhD/MS with 3+ years or BS with 5+ years in analytical chemistry or related field.
HPLC, UHPLC, SEC, ELISA, DLS, UV-Vis, CE, mass spectrometry
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
2+ YOEExperience in analytical method development/validation with chromatography techniques; PhD+2yrs or MS+5yrs (or BS+8yrs); strong data interpretation, troubleshooting, GMP knowledge, and communication skills.
Cambrex: Contract development and manufacturing organization for the pharmaceutical industry.
2+ YOEM.S. in chemistry with 2+ years or B.S. with 6+ years laboratory experience; GMP experience; ability to develop, validate and transfer analytical methods; strong communication and organizational skills.
0+ YOEExpertise in protein mass spectrometry and bioanalytical techniques; method development/transfer for cGMP testing; data analysis and technical reporting. PhD preferred; MS with 2+ years relevant experience considered.
Aurion Biotech: Developing regenerative cell therapies to restore vision for patients.
3+ YOEPhD (3–5 years) or MS (6–8 years) in related field with demonstrated analytical development experience for cell therapies; deep technical knowledge of assays (Flow Cytometry, dPCR/qPCR, ELISA, potency) and GMP method development; strong cross-functional collaboration and documentation skills.
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
10+ YOEPhD or Masters; 10+ years in analytical development; leadership in cross-functional teams; experience with small molecule programs; regulatory submissions experience.
NeurogeneNASDAQ: NGNE: Develops genetic medicines for rare neurological diseases.
10+ YOE5+ MgmtPh.D. in a related field, minimum 10 years relevant experience with at least 5 years management; deep expertise in AAV analytics, assay development/validation, cGMP, regulatory interactions, and comparability strategies.
Artiva BiotherapeuticsNASDAQ: ARTV: Develops allogeneic natural killer cell-based therapies for various diseases.
10+ YOEPhD with 10+ years industry analytical development experience, expertise in cell-based potency assays, assay validation, flow cytometry, ELISA/MSD, qPCR/ddPCR, regulatory writing, and scientific leadership.